Cover Image

PAPERBACK
$63.25



View/Hide Left Panel

Appendix A
Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults

Lecture Room

National Academy of Sciences Building

2101 Constitution Avenue NW

Washington, D.C. 20418

January 26–27, 2004

Day 1

8:30–9:00

Continental Breakfast, Lecture Room

9:00–9:30

Welcome and Introduction to the Workshop

Louise Russell, Ph.D., Rutgers University, Workshop Chair

Martin Brown, Ph.D., National Cancer Institute, Workshop Co-Chair

Judith Wagner, Ph.D., IOM Staff Officer

PART I: COMPARING ECONOMIC MODELS OF CRC SCREENING

9:30–11:00

Overview of Five Leading Economic Models of CRC Screening

The “Harvard Model”: Karen Kuntz, Sc.D., Harvard University

The “Ladabaum Model”: Uri Ladabaum, M.D., University of California at San Francisco

The “Miscan Model”: Marjolein van Ballegooijen, M.D., Erasmus University

The “Vanderbilt Model”: Reid Ness, M.D., Vanderbilt University

The “Vijan Model”: Sandeep Vijan, M.D., University of Michigan

11:00–11:15

Break

11:15–11:45

Results of a Pre-Workshop Comparative Modeling Exercise

Michael Pignone, M.D., University of North Carolina

11:45–12:45

Discussion

12:45–1:15

Lunch

PART II: CURRENT EVIDENCE ON COLORECTAL CANCER SCREENING

1:15–2:30

Evidence on Compliance (Q&A follows presentations)

 

Current Evidence on Compliance

Sally Vernon, Ph.D., University of Texas at Houston



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 35
Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary Appendix A Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults Lecture Room National Academy of Sciences Building 2101 Constitution Avenue NW Washington, D.C. 20418 January 26–27, 2004 Day 1 8:30–9:00 Continental Breakfast, Lecture Room 9:00–9:30 Welcome and Introduction to the Workshop Louise Russell, Ph.D., Rutgers University, Workshop Chair Martin Brown, Ph.D., National Cancer Institute, Workshop Co-Chair Judith Wagner, Ph.D., IOM Staff Officer PART I: COMPARING ECONOMIC MODELS OF CRC SCREENING 9:30–11:00 Overview of Five Leading Economic Models of CRC Screening The “Harvard Model”: Karen Kuntz, Sc.D., Harvard University The “Ladabaum Model”: Uri Ladabaum, M.D., University of California at San Francisco The “Miscan Model”: Marjolein van Ballegooijen, M.D., Erasmus University The “Vanderbilt Model”: Reid Ness, M.D., Vanderbilt University The “Vijan Model”: Sandeep Vijan, M.D., University of Michigan 11:00–11:15 Break 11:15–11:45 Results of a Pre-Workshop Comparative Modeling Exercise Michael Pignone, M.D., University of North Carolina 11:45–12:45 Discussion 12:45–1:15 Lunch PART II: CURRENT EVIDENCE ON COLORECTAL CANCER SCREENING 1:15–2:30 Evidence on Compliance (Q&A follows presentations)   Current Evidence on Compliance Sally Vernon, Ph.D., University of Texas at Houston

OCR for page 35
Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary   Recent Follow-up and Compliance Patterns of Medicare Patients Todd Anderson, M.S., Congressional Budget Office   The Relationship Between Compliance and Capacity Laura Seeff, M.D., Centers for Disease Control 2:30–3:15 Recent Findings on Test Performance Brian Mullhall, M.D., Walter Reed Army Hospital Q&A follows presentation 3:15–3:30 Break 3:30–4:15 Measuring the Cost of Screening, Follow-up, and Surveillance in Cost-Effectiveness Models Martin Brown, Ph.D. National Cancer Institute Q&A follows presentation 4:15–5:00 Evidence on Effectiveness of Follow-up and Surveillance Strategies Deborah Schrag, M.D., Memorial Sloan Kettering Cancer Center Q&A follows presentation Day 2 8:30–9:00 Defining Issues: A Reprise of First Day’s Findings Martin Brown, Michael Pignone, and Judith Wagner PART III: MODELING THE NATURAL HISTORY OF COLORECTAL CANCER 9:00–9:45 Recent Evidence on Natural History T.R.Levin, M.D., Kaiser Permanente Division of Research Q&A follows presentation 9:45–10:00 The NCI CISNET Project: An Overview of Goals, Methods, and Current Status Eric Feuer, Ph.D., National Cancer Institute 10:00–10:15 Break 10:15–11:15 Discussion of Issues in Modeling Natural History 11:15–12:00 Modelers’ Forum: Next Steps, Unresolved Questions, Critical Information Needs Marjolein van Ballegooijen, Karen Kuntz, Sandeep Vijan, Reid Ness, Uri Ladabaum and Coauthors 12:00–1:00 Discussion and Wrap-up 1:00 Adjourn